Paromomycin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01421 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 97 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 2 | hepatoportal sclerosis | KG + DL |
| 3 | primitive portal vein thrombosis | KG + DL |
| 4 | hepatopulmonary syndrome | KG + DL |
| 5 | idiopathic copper-associated cirrhosis | KG + DL |
| 6 | hepatic porphyria | KG + DL |
| 7 | acute urate nephropathy | KG + DL |
| 8 | peritonitis | KG + DL |
| 9 | exercise-induced malignant hyperthermia | KG + DL |
| 10 | nephrolithiasis | KG + DL |
| 11 | glycogen storage disease due to hepatic glycogen synthase deficiency | KG + DL |
| 12 | unclassified intestinal pseudoobstruction | KG + DL |
| 13 | myopathic intestinal pseudoobstruction | KG + DL |
| 14 | familial visceral myopathy | KG + DL |
| 15 | hyperphenylalaninemia due to tetrahydrobiopterin deficiency | KG + DL |
| 16 | intestinal obstruction | KG + DL |
| 17 | idiopathic eosinophilic myositis | KG + DL |
| 18 | inflammatory myopathy with abundant macrophages | KG + DL |
| 19 | immune-mediated necrotizing myopathy | KG + DL |
| 20 | neonatal epileptic encephalopathy due to glutaminase deficiency | KG + DL |
| 21 | malignant hyperthermia, susceptibility to | KG + DL |
| 22 | antisynthetase syndrome | KG + DL |
| 23 | focal myositis | KG + DL |
| 24 | phenylketonuria | KG + DL |
| 25 | genetic otorhinolaryngological malformation | KG + DL |
| 26 | semicircular canal dehiscence syndrome | KG + DL |
| 27 | idiopathic bilateral vestibulopathy | KG + DL |
| 28 | inborn disorder of phenylalanin or tyrosine metabolism | KG + DL |
| 29 | epiglottitis | KG + DL |
| 30 | neuronal intestinal dysplasia, type B | KG + DL |
| 31 | tetrahydrobiopterin metabolic process disease | KG + DL |
| 32 | familial nasal acilia | KG + DL |
| 33 | disorder of phenylalanine metabolism | KG + DL |
| 34 | juvenile nasopharyngeal angiofibroma (disease) | KG + DL |
| 35 | acute pulmonary heart disease | KG + DL |
| 36 | silent sinus syndrome | KG + DL |
| 37 | maternal hyperthermia induced birth defects | KG + DL |
| 38 | craniorhiny | KG + DL |
| 39 | cleft lip/palate-intestinal malrotation-cardiopathy syndrome | KG + DL |
| 40 | fetal minoxidil syndrome | KG + DL |
| 41 | phenobarbital embryopathy | KG + DL |
| 42 | Bencze syndrome | KG + DL |
| 43 | fetal trimethadione syndrome | KG + DL |
| 44 | mandibulofacial dysostosis-macroblepharon-macrostomia syndrome | KG + DL |
| 45 | velo-facial-skeletal syndrome | KG + DL |
| 46 | congestive heart failure | KG + DL |
| 47 | branchial cleft anomaly | KG + DL |
| 48 | renal tubular acidosis | KG + DL |
| 49 | disorder of tyrosine metabolism | KG + DL |
| 50 | diabetic embryopathy | KG + DL |
(Showing top 50 of 97 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.